Innovations in Clinical Development Keys to Success: Innovation, Diverse Talent, and Leadership


Virtual - Zoom  
Tuesday, March 01, 2022 7:00 PM - 8:30 PM   Add to Calendar Eastern Standard Time

Please join us for the second in our three-part series that is focused on introducing HBA members to the evolution of the life sciences industry over the past 20 years, and the leading role that Boston has played in it. Starting with The Human Genome Project, the latest cutting-edge innovations in genetic editing, precision medicines and AI all contribute to advancing the development of treatments for chronic and rare diseases. This series of HBA programs will explore what has driven the great strides made in therapeutic and disease advancement as well as how to adapt to the realities and dynamics of clinical development today. In this event, Nina Wachsman, CEO and founder of KnowRare, will moderate a panel of experts from varied sectors to gain their diverse perspectives on the successes and challenges in the development of therapies for rare diseases. She will be joined by Katherine Beaverson, Senior Director and Patient Advocacy Lead, Rare Disease Research Unit, Pfizer; Julie Ross, President, Advanced Clinical; and Dr. Pushpa Narayanaswami MD, FAAN Vice- Chair, Clinical Operations, Dept. of Neurology, Beth Israel Deaconess Medical Center; Associate Professor of Neurology Harvard Medical School. This panel will discuss the keys to successful and timely delivery of much needed medicines to patients.

HBA Boston presents

Innovations in Clinical Development Keys to Success: Innovation, Diverse Talent, and Leadership


Date and time
Tuesday, 01 March
07:00PM - 08:30PM EST
Location
Virtual - Zoom

Event Contact
Crystal Shih
Competencies
3. Exhibits business and industry acumen
Event Sponsor


Please join us for the second in our three-part series that is focused on introducing HBA members to the evolution of the life sciences industry over the past 20 years, and the leading role that Boston has played in it. Starting with The Human Genome Project, the latest cutting-edge innovations in genetic editing, precision medicines and AI all contribute to advancing the development of treatments for chronic and rare diseases. This series of HBA programs will explore what has driven the great strides made in therapeutic and disease advancement as well as how to adapt to the realities and dynamics of clinical development today.

In this event, Nina Wachsman, CEO and founder of KnowRare, will moderate a panel of experts from varied sectors to gain their diverse perspectives on the successes and challenges in the development of therapies for rare diseases. She will be joined by Katherine Beaverson, Senior Director and Patient Advocacy Lead, Rare Disease Research Unit, Pfizer; Julie Ross, President, Advanced Clinical and 2022 Vice Chair on HBA Board of Directors; and Dr. Pushpa Narayanaswami MD, FAAN Vice Chair, Clinical Operations, Dept. of Neurology, Beth Israel Deaconess Medical Center and Associate Professor of Neurology Harvard Medical School. This panel will discuss the keys to successful and timely delivery of much needed medicines to rare disease patients.


Registration information
Event is open to: HBA Members and Nonmembers

Cancellations/refunds
This event is refundable, requests must be submitted in writing to events@hbanet.org by 26 February 2022

Featured Speakers

Katherine  Beaverson
Senior Director and Patient Advocacy Lead, Rare Disease Research Unit
Pfizer Inc.
Pushpa  Narayanaswami
Vice-Chair, Clinical operations, BIDMC. Associate Professor of Neurology, Harvard Medical School
Beth Israel Deaconess Medical Center
Julie  Ross
President
Advanced Clinical
NIna  Wachsman
CEO, Co-Founder
Know Rare/ Know Healthtech, Inc.
Learning Objectives
• Discuss successes and challenges in developing therapeutics in treatment of rare disease.
• Identify the keys for success in clinical innovation.

Registration information

The registration button at the bottom of the page will not show if online registration has closed or if the event has reached capacity. If you are a guest and the registration button is not showing, it may be that this is a member-only event. Read more about the benefits of membership or contact us about membership.

The HBA will make reasonable modifications to policies and programs to ensure that people with special needs have an equal opportunity to enjoy all of its programs. Contact us if you require special accommodations for this event.

 Price LevelRegular
Collapse group

Registration: Regular Registration

 Member$10.00
 Member - Euro€8.00
 Non-Member$20.00
 Non-Member - Euro€17.00

By registering for this event, you acknowledge that you may be photographed, videotaped and/or audio-taped during the course of the meeting and hereby give permission for your image, voice, or survey comments to be used in education, training, promotion and/or trade and communications media by the Healthcare Businesswomen's Association in any and all media throughout the world, without restriction as to frequency or duration of usage.